David M. Berman is HEAD OF R&D at Immunocore Holdings plc (IMCR). They have made 1 open-market trade across 1 company since 2024, most recently 2026-02-18.
CIK 0001955244
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMCR | 11,824 | $348K |
Shares reported on the most recent Form 4, priced at the 2026-02-19 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMCR | SELL | 2026-02-18 | 2026-02-19 | $32.35 | $193K | -2.6% | -8.4% | -11.1% |
| IMCR | SELL · 10b5-1 | 2025-12-04 | 2025-12-08 | $40.26 | $2.5M | -5.6% | -11.2% | -12.1% |
| IMCR | SELL · 10b5-1 | 2025-11-26 | 2025-12-01 | $40.12 | $6.0M | -4.2% | -7.1% | -12.6% |
| IMCR | SELL · 10b5-1 | 2025-11-24 | 2025-11-26 | $40.03 | $1.4M | -8.4% | -9.7% | -15.8% |
| IMCR | SELL · 10b5-1 | 2025-09-30 | 2025-10-02 | $35.23 | $4.4M | -9.3% | -7.5% | -0.8% |
| IMCR | SELL · 10b5-1 | 2025-09-12 | 2025-09-16 | $35.65 | $1.6M | +1.3% | -0.1% | +7.3% |
| IMCR | SELL · 10b5-1 | 2025-09-10 | 2025-09-12 | $36.19 | $3.6M | -2.1% | -7.6% | +2.3% |
| IMCR | SELL · 10b5-1 | 2024-02-28 | 2024-03-01 | $68.85 | $3.8M | -9.4% | -7.7% | -31.5% |
| IMCR | SELL · 10b5-1 | 2024-02-26 | 2024-02-28 | $70.79 | $11.8M | -14.4% | -11.6% | -35.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.